Literature DB >> 10418864

Colles' fracture: management by percutaneous crossed-pin fixation versus plaster of Paris cast immobilization.

R Gupta1, A Raheja, U Modi.   

Abstract

Colles' fracture is the most common fracture seen in orthopedic practice, but no consensus has been reached on an effective method to maintain the initial reduction achieved. This prospective, randomized study of 50 patients evaluates the efficacy of maintaining reduction and consequent functional end results of two treatment methods, ie, percutaneous crossed-pin fixation followed by plaster of Paris cast immobilization with the wrist in functional position versus conventional plaster of Paris cast immobilization. The anatomical and functional end results were significantly better with percutaneous crossed-pin fixation at final follow-up.

Entities:  

Mesh:

Year:  1999        PMID: 10418864

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  4 in total

1.  Percutaneous pinning for treating distal radial fractures in adults.

Authors:  Alexia Karantana; Helen Hg Handoll; Ammar Sabouni
Journal:  Cochrane Database Syst Rev       Date:  2020-02-07

2.  Distal Radius Fractures: Evaluation of Closed Reduction and Percutaneous Kirschner Wire Pinning.

Authors:  Sezai Özkan; Ritsaart F Westenberg; Lydia A Helliwell; Chaitanya S Mudgal
Journal:  J Hand Microsurg       Date:  2018-05-28

Review 3.  Influence of osteoporosis on fracture fixation--a systematic literature review.

Authors:  J Goldhahn; N Suhm; S Goldhahn; M Blauth; B Hanson
Journal:  Osteoporos Int       Date:  2008-06       Impact factor: 4.507

4.  What Is the Relative Effectiveness of the Various Surgical Treatment Options for Distal Radius Fractures? A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.

Authors:  Taylor Woolnough; Daniel Axelrod; Anthony Bozzo; Alex Koziarz; Frank Koziarz; Colby Oitment; Lauren Gyemi; Jessica Gormley; Kyle Gouveia; Herman Johal
Journal:  Clin Orthop Relat Res       Date:  2021-02-01       Impact factor: 4.755

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.